Canadian Cancer Trials Group Bulletins

General


ASCO 2016

A number of abstracts related to CCTG trials or trials which included CCTG participation will be presented at the 2016 Annual American Society of Clinical Oncology Annual Meeting, including final results of MA.17R and CE.6.

CCTG CE.6 - PLENARY SESSION
A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma (CCTG CE.6, EORTC 26062-22061, TROG 08.02, NCT00482677)
Session Title: Plenary Session Including the Science of Oncology Award and Lecture
Date: Sunday, June 5
Session Type: Plenary Session
Time: 1:00 PM to 4:00 PM
Location: Hall B1

Authors: James R. Perry, Normand Laperriere, Christopher J. O'Callaghan, Alba Ariela Brandes, Johan Menten, Claire Phillips, Michael F. Fay, Ryo Nishikawa, J. Gregory Cairncross, Wilson Roa, David Osoba, Arjun Sahgal, Hal W. Hirte, Wolfgang Wick, Florence Laigle-Donadey, Enrico Franceschi, Olivier L. Chinot, Chad Winch, Keyue Ding, Warren P. Mason

______________________________

CCTG MA.17R - PLENARY SESSION:
A randomized trial (MA.17R) of extending adjuvant letrozole for 5 years after completing an initial 5 years of aromatase inhibitor therapy alone or preceded by tamoxifen in postmenopausal women with early-stage breast cancer.
Session Title: Plenary Session Including the Science of Oncology Award and Lecture
Date: Sunday, June 5
Session Type: Plenary Session
Time: 1:00 PM to 4:00 PM

Location: Hall B1; Abstract #LBA1
Authors: Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Hyman Muss, Julie Gralow, Karen A. Gelmon, Timothy Joseph Whelan, Kathrin Strasser-Weippl, Sheldon Rubin, Keren Sturtz, Antonio C. Wolff, Eric P. Winer, Clifford A. Hudis, Alison Stopeck, J. Thaddeus Beck, Judith Salmon Kaur, Kate Whelan, Dongsheng Tu, Wendy R. Parulekar

For a complete listing of abstracts being presented, please see this link ... https://www.ctg.queensu.ca/public/publications/conference-presentations.